Viewpoint: ‘Just the flu’: Skipping your child’s flu shot could be a fatal mistake Zachary Yaksich | November 4, 2026

https://geneticliteracyproject.org/2026/11/04/viewpoint-just-the-flu-skipping-your-childs-flu-shot-could-be-a-fatal-mistake/ In 2003, my life was completely shattered. My daughter, Alana, was 5½ years old when she died from complications of influenza. My family and children had received all of their childhood vaccinations on schedule and as recommended by the Centers for Disease Control and Prevention (CDC), but in 2003, the age recommendation for influenza vaccination was 6 months through 59 months. Alana was older than that. She had not received a flu vaccine, nor had her pediatrician ever recommended one to us or explained the dangers that influenza could pose to a child.

Business of Medicine News: Workload Rises as More Patients Take GLP-1s (+...)

Business of Medicine News Workload Rises as More Patients Take GLP-1s More patients on GLP-1s means more questions, more paperwork, and more follow-ups, and primary care is absorbing much of it. Medscape Medical News, November 04, 2026 https://www.medscape.com/index/list_13469_0

European News & Perspectives: Sleepmaxxing: Is the Pursuit of Perfect Sleep Backfiring? (+...)

European News & Perspectives Sleepmaxxing: Is the Pursuit of Perfect Sleep Backfiring? From mouth taping to sleep scores, popular strategies raise questions about safety, evidence, and when efforts to improve rest warrant clinical attention. Medscape News Europe, November 04, 2026 https://www.medscape.com/index/list_15988_0

Medscape Medical News: mRNA-Based RSV Vaccine Cuts Infection Risk in Veterans (+...)

Medscape Medical News mRNA-Based RSV Vaccine Cuts Infection Risk in Veterans A single mRNA-1345 dose lowers the risk for RSV infection, urgent care visits, and hospitalization in veterans aged 50 years or older, a study shows. Medscape Medical News, November 04, 2026 https://www.medscape.com/index/list_11861_0

Oncology News: Platelet Count, CRP Tied to Cancer Risk Across Ethnicities (+...)

Oncology News Platelet Count, CRP Tied to Cancer Risk Across Ethnicities Elevated platelet counts and CRP levels are tied to a risk for cancer among White, Asian, and Black patients in primary care, with stronger associations with colorectal cancer among Black patients. Medscape News UK, November 04, 2026 https://www.medscape.com/index/list_13474_0

A safe home for every child and adolescent The Lancet Child & Adolescent Health (+...)

A safe home for every child and adolescent The Lancet Child & Adolescent Health https://www.thelancet.com/journals/lanchi/issue/vol10no12/PIIS2352-4642(26)X2010-7 Adequate housing is foundational to human rights and dignity, as highlighted by the theme of Safe Homes for All for this year's International Day for the Eradication of Poverty. According to the Sustainable Development Goal (SDG) 11 Global Report 2026, at least 3 billion people worldwide live in inadequate housing, with more than 1·16 billion—nearly one in four urban residents—living in slums and informal settlements, with limited access to safe water, sanitation, secure housing, or adequate living space. The SDG 11 report has little disaggregation by age, but UNICEF estimates that 23% of children in low-income countries and 20·5% in lower-middle-income countries experience severe housing deprivation. Housing unaffordability and homelessness are on the rise—55% of households in sub-Saharan Africa, 50% in Europe and Northern America, and 48% in Latin America and the Caribbean are spending more than 30% of their incomes on housing-related expenses. In England, the number of children living in temporary accommodation (177 530) reached a record high in 2026; in the USA, more than 1·54 million public school students experienced homelessness in 2023–24.

FDA Grants Accelerated Approval to Voceryq for Recurrent Respiratory Papillomatosis by Madaline Spencer| Published on: Nov 3, 2026

https://checkrare.com/fda-grants-accelerated-approval-to-voceryq-for-recurrent-respiratory-papillomatosis/ FDA Grants Accelerated Approval to Voceryq for Recurrent Respiratory Papillomatosis by Madaline Spencer| Published on: Nov 3, 2026 The US Food and Drug Administration (FDA) has granted accelerated approval to Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd), previously referred to as INO-3107, to reduce the frequency of surgery in adults with recurrent respiratory papillomatosis (RRP).